Treatment of Parkinson patients
Ludin, H.P.
Praxis 90(23): 1007
2001
ISSN/ISBN: 1661-8157 PMID: 11447719 Document Number: 539113
Document emailed within 1 workday
Related Documents
Cassani, E.; Privitera, G.; Pezzoli, G.; Pusani, C.; Madio, C.; Iorio, L.; Barichella, M. 2011: Use of probiotics for the treatment of constipation in Parkinson's disease patients Minerva Gastroenterologica e Dietologica 57(2): 117-121Sobolewski, P. 2003: Treatment of Parkinson disease in patients with surgical problems Neurologia i Neurochirurgia Polska 37(Suppl 5): 183-188
Stern, P.H.; McDowell, F.; Miller, J.M.; Robinson, M. 1970: Levodopa and physical therapy in treatment of patients with Parkinson's disease Archives of Physical Medicine and Rehabilitation 51(5): 273-277
Campanella, G.; Zallone, E.; Buscaino, G.A. 1972: Amantadine in the treatment of Parkinson's syndrome: studied in 31 patients for 3 months Acta Neurologica 27(5): 491-500
Sage, J.I.; Trooskin, S.; Sonsalla, P.K.; Heikkila, R.E. 1989: Experience with continuous enteral levodopa infusions in the treatment of 9 patients with advanced Parkinson's disease Neurology 39(11 Suppl 2: 60
Buscaino, G.A.; Sori, A.; Campanella, G. 1972: Study of dopamine and noradrenaline in the brains of three patients with Parkinson's disease who died in the course of treatment with L-dopa Revue Neurologique (Paris) 127(2): 301-302
Tanasanvimon, S.; Ayuthaya, N.I.N.; Phanthumchinda, K. 2007: Modified Parkinson's Disease Sleep Scale (MPDSS) in Thai Parkinson's disease patients Journal of the Medical Association of Thailand 90(11): 2277-2283
Rasmussen, V.G.; Poulsen, S.H.; Dupont, E.; Østergaard, K.; Safikhany, G.; Egeblad, H. 2009: Heart abnormalities in Parkinson patients after discontinuation or continuation of ergot-derived dopamine agonists: a treatment-blinded echocardiographic study Journal of Heart Valve Disease 18(4): 463-469
Arai, M. 2012: Levodopa in combination with carbidopa does not affect plasma arginine vasopressin levels in treatment-naïve older patients with Parkinson's disease: a before-after study Neuro Endocrinology Letters 33(1): 34-36
Lökk, J. 2003: Treatment with levodopa can affect latent vitamin B 12 and folic acid deficiency. Patients with Parkinson disease runt the risk of elevated homocysteine levels Lakartidningen 100(35): 2674-2677
Rabasseda, X. 1999: Perspectives in the treatment of Parkinson's disease: COMT inhibitors open up new treatment strategies Drugs of Today 35(9): 701-717
Poungvarin, N.; Viriyavejakul, A. 1990: L-deprenyl therapy in Thai patients with Parkinson's disease: before and after, clinical trial of 50 patients Journal of the Medical Association of Thailand 73(7): 381-386
Fischer, P.A. 1987: Long-term course in Parkinson's syndrome and cerebral polypathy (Parkinson plus) Advances in Neurology 45: 235-238
De Quintana-Schmidt, C.; Pascual-Sedano, B.; Alvarez-Holzapfel, M.J.ús.; Gironell, A.; Leidinger, A.; Benito, N.; Rodríguez-Rodríguez, R.; Molet-Teixidó, J. 2014: Complications related with implanted devices in patients with Parkinson's disease treated with deep brain stimulation. a study of a series of 124 patients over a period of 16 years Revista de Neurologia 59(2): 49-56
Vijayaraghavan, A.; Radhakrishnan, K. 1996: Treatment of Parkinson's disease Neurology India 44(4): 177-182
Grieger, T.A.; Cozza, K.; Armstrong, S. 1994: Treatment of Parkinson's disease New England Journal of Medicine 330(9): 643-644
Bergus, G. 1996: Treatment of Parkinson's disease Journal of Family Practice 42(5): 457-458
Jameson, H.D. 1972: Treatment of Parkinson's disease Journal of the Kentucky Medical Association 70(4): 304-307
Vijayaraghavan, A.; Radhakrishnan, K. 1995: Treatment of Parkinson's disease Neurology India 43(2): 77-82
Jiménez-Jiménez, F.J. 1999: The treatment of Parkinson disease Medicina Clinica 112(7): 257-258